Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics

This study has been terminated.
(Difficulty enrolling eligible subjects)
Sponsor:
Collaborator:
Eyetech Pharmaceuticals
Information provided by:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00346983
First received: June 29, 2006
Last updated: May 8, 2008
Last verified: May 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2007
  Primary Completion Date: April 2007 (Final data collection date for primary outcome measure)